317 related articles for article (PubMed ID: 7926767)
1. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren R; Ye ZS; Baltimore D
Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
3. c-Abl kinase regulates the protein binding activity of c-Crk.
Feller SM; Knudsen B; Hanafusa H
EMBO J; 1994 May; 13(10):2341-51. PubMed ID: 8194526
[TBL] [Abstract][Full Text] [Related]
4. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
5. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
6. Crk family adaptor proteins trans-activate c-Abl kinase.
Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
[TBL] [Abstract][Full Text] [Related]
7. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
Oda T; Kujovich J; Reis M; Newman B; Druker BJ
Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
[TBL] [Abstract][Full Text] [Related]
9. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
[TBL] [Abstract][Full Text] [Related]
10. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
14. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
15. Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation.
Buday L; Khwaja A; Sipeki S; Faragó A; Downward J
J Biol Chem; 1996 Mar; 271(11):6159-63. PubMed ID: 8626404
[TBL] [Abstract][Full Text] [Related]
16. The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins.
Oehrl W; Kardinal C; Ruf S; Adermann K; Groffen J; Feng GS; Blenis J; Tan TH; Feller SM
Oncogene; 1998 Oct; 17(15):1893-901. PubMed ID: 9788432
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
J Biol Chem; 1996 Jun; 271(24):14468-72. PubMed ID: 8662907
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
20. A potential SH3 domain-binding site in the Crk SH2 domain.
Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
